Drug-device Safety Reporting

A biologics manufacturer and a medical device manufacturer engaged in collaborative development of a prefilled delivery system sought Chimera’s advice on how to structure their safety reporting systems to assure compliance with both biologic and device safety reporting requirements. Chimera worked with the pharmaceutical manufacturer to establish interim policy and SOPs for submitting safety reports to a BLA during the period while the proposed combination products systems safety rule remains in draft.